Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Francisco Machado-Linde is active.

Publication


Featured researches published by Francisco Machado-Linde.


Fetal Diagnosis and Therapy | 2011

Fertility Preservation in Heterotopic Cervical Pregnancy: What Is the Best Procedure?

María Luisa Sánchez-Ferrer; Francisco Machado-Linde; Miriam Pertegal-Ruiz; Francisco García-Sánchez; Antonio Pérez-Carrión; Antonio Capel-Alemán; Juan José Parilla-Paricio; Lorenzo Abad-Martínez

We describe a patient who underwent assisted reproduction techniques and was diagnosed with heterotopic cervical pregnancy, and then discuss the management of this entity, which is rare and has no standard protocols. Treatment consisted of intra-arterial methotrexate (50 mg/m2 body surface area) and simultaneous selective embolization of uterine arteries. The literature is also reviewed to identify other approaches and outcomes.


Gynecologic and Obstetric Investigation | 2014

Uterine rupture in twin pregnancy with normal fetus and complete hydatidiform mole.

María Luisa Sánchez-Ferrer; Florentina Hernández-Martínez; Francisco Machado-Linde; Belén Ferri; Pablo Carbonel; Anibal Nieto-Diaz

We describe a rare case of complete hydatidiform mole with twin live fetus (CHMTF) confirmed by histopathology, flow cytometry and polymerase chain reaction techniques. No malformations were observed, fetal karyotype was normal and β-human chorionic gonadotropin levels were high (>100,000 IU/ml). The patient was informed of the risks and decided to continue with the pregnancy, but at week 15, she had to undergo hysterectomy due to uterine rupture. She subsequently developed persistent trophoblastic disease (PTD) with pulmonary metastases that required treatment with polychemotherapy. Patients with CHMTF should be informed of all known risks, including the considerable risk of PTD, which is similar to or, even higher than that associated with a singleton complete mole. The risk does not appear to be increased by continuing the pregnancy. Because so few series have been published, there is a lack of evidence-based clinical management guidelines. To our knowledge, this is the first report of uterine rupture in CHMTF.


International Urogynecology Journal | 2015

Conservative management of vesico-vaginal fistula after uterine and partial bladder necrosis due to embolization as a treatment for postpartum hemorrhage

Pilar Marín-Sánchez; María Luisa Sánchez-Ferrer; Francisco Machado-Linde

Postpartum haemorrhage is a major cause of maternal mortality worldwide, and uterine atony its most common cause. Selective uterine artery embolization (UAE) is a safe conservative second-line treatment after uterotonics or uterine tamponade have failed and before surgical techniques are used in hemodynamically stable patients. Response rates range from 75-100 %. Complications are rare (6-9 %). Most common is postembolization syndrome (self-limited fever and pain within the first 24-48 hours). A rare (22 cases found) and severe complication is uterine necrosis, isolated or with bladder involvement (only three cases reported). All were treated with surgery (hysterectomy and partial cystectomy in cases with associated bladder necrosis). Regarding a vesicovaginal fistula after embolization, only 3 cases have been reported [1–3]. All resulted in hysterectomy (either total or subtotal).


Fetal Diagnosis and Therapy | 2013

Management of a Dichorionic Twin Pregnancy with a Normal Fetus and an Androgenetic Diploid Complete Hydatidiform Mole

María Luisa Sánchez-Ferrer; Francisco Machado-Linde; Alicia Martínez-Espejo Cerezo; Carolina Peñalver Parres; Belén Ferri; Isabel López-Expósito; Lorenzo Abad; Juan José Parrilla

We describe a rare case of complete hydatidiform mole with twin live fetus (CHMTF) confirmed by histopathology, flow cytometry, and polymerase chain reaction techniques. No malformations were observed, fetal karyotype was normal and β-human chorionic gonadotropin levels were increased (>100,000 IU/ml). Once the patient had been informed of the risks, it was decided to continue the pregnancy, but termination of pregnancy was necessary at week 13 + 5 due to maternal complications consisting of hyperthyroidism, hypertension and vaginal bleeding, followed by persistent trophoblastic disease (PTD). Patients diagnosed with CHMTF should be informed of all known risks, including the considerable risk of PTD, which is similar to - or according to some reports - even higher than that associated with a singleton complete mole and is not increased by continuing pregnancy. Due to the low number of series published, evidence-based clinical management guidelines are lacking.


Journal of Obstetrics and Gynaecology | 2017

Central pontine myelinolysis during pregnancy: Pathogenesis, diagnosis and management

María Luisa Sánchez-Ferrer; María T. Prieto-Sánchez; Rodrigo Orozco-Fernández; Francisco Machado-Linde; Anibal Nieto-Diaz

Abstract Central pontine myelinolysis (CPM) is a rare condition usually caused by rapid sodium correction in hyponatraemia after a severe neurological syndrome. Only few cases have been reported during pregnancy, most of which were reported in patients with hyperemesis. We describe the successful management of the first case of twin pregnancy in a patient who presented with CPM after treatment for premature labour and then review the literature on CPM in pregnancy (aetiology, diagnosis and management). Our patient required emergency delivery to achieve electrolyte and fluid balance. At six months, the twins remained asymptomatic and the mother had minor sequelae. The aetiology is not clear, and there is no evidence regarding the optimal treatment or prognosis of CPM. In our patient, desmopressin-contaminated atosiban showed a certain probability in the Karch-Lasagne algorithm of a causality relationship between hyponatraemia and the drug. To our knowledge, this is the first case of myelinolysis reported in a twin pregnancy possibly related to desmopressin-contaminated atosiban.


Scientific Reports | 2018

Characterization of human peritoneal monocyte/macrophage subsets in homeostasis: Phenotype, GATA6, phagocytic/oxidative activities and cytokines expression

Antonio J. Ruiz-Alcaraz; Violeta Carmona-Martínez; María Tristán-Manzano; Francisco Machado-Linde; María Luisa Sánchez-Ferrer; Pilar García-Peñarrubia; María Martínez-Esparza

Peritoneal macrophages play a critical role in the control of infectious and inflammatory diseases. Although recent progress on murine peritoneal macrophages has revealed multiple aspects on their origin and mechanisms involved in their maintenance in this compartment, little is known on the characteristics of human peritoneal macrophages in homeostasis. Here, we have studied by flow cytometry several features of human peritoneal macrophages obtained from the peritoneal cavity of healthy women. Three peritoneal monocyte/macrophage subsets were established on the basis of CD14/CD16 expression (CD14++CD16−, CD14++CD16+ and CD14highCD16high), and analysis of CD11b, CD11c, CD40, CD62L, CD64, CD80, CD86, CD116, CD119, CD206, HLA-DR and Slan was carried out in each subpopulation. Intracellular expression of GATA6 and cytokines (pro-inflammatory IL-6 and TNF-α, anti-inflammatory IL-10) as well as their phagocytic/oxidative activities were also analyzed, in an attempt to identify genuine resident peritoneal macrophages. Results showed that human peritoneal macrophages are heterogeneous regarding their phenotype, cell complexity and functional abilities. A direct relationship of CD14/CD16 expression, intracellular content of GATA6, and activation/maturation markers like CD206 and HLA-DR, support that the CD14highCD16high subset represents the mature phenotype of steady-state human resident peritoneal macrophages. Furthermore, increased expression of CD14/CD16 is also related to the phagocytic activity.


International Journal of Gynecology & Clinical Practices | 2014

Current Controversies in Stem-Cell Treatment of Urinary Incontinence in Women

Maria Luisa Sanchez Ferrer; Francisco Machado-Linde; María T. Prieto-Sánchez; Anibal Nieto-Diaz

Background: Urinary incontinence (UI) is a major cause of morbidity in the world and is believed to affect up to 46% of the female population Our objective was to analyze the papers that describe stem-cell treatments for UI in women. Methods: We performed a systematic review of the literature from 1946 to date that reports on clinical trials that use stem cells to treat women with urinary incontinence. Results: Nine articles (7 observational and 2 randomized studies) met the inclusion criteria. No major adverse effects were observed in any of the studies. However, the efficacy results differ widely, as the methodology used for studies was very different, as described below. Conclusion: Stem-cell therapy is promising but still experimental, and further study is needed to identify certain factors. These facts include the ideal type of patient eligible for treatment (apparently those in whom intrinsic urethral dysfunction predominates), and to determine if treatment should be isolated or combined with other cells or procedures, which are the optimal doses and if it is a cost effective procedure.


Reproductive Biomedicine Online | 2017

Investigation of anogenital distance as a diagnostic tool in endometriosis

María Luisa Sánchez-Ferrer; Jaime Mendiola; Raquel Jiménez-Velázquez; Laura Cánovas-López; Shiana Corbalán-Biyang; Ana I. Hernández-Peñalver; Ana Carmona-Barnosi; Ana B. Maldonado-Cárceles; María T. Prieto-Sánchez; Francisco Machado-Linde; Aníbal Nieto; Alberto M. Torres-Cantero


International Urogynecology Journal | 2017

Vesicouterine fistula: teaching video on diagnosis and surgical treatment

Pilar Marín-Sánchez; María Luisa Sánchez-Ferrer; Clara Garrido-Navarro; Antonio Prieto-Gonzalez; Francisco Machado-Linde


Archive | 2014

Current Controversies in Stem-Cell Treatment of Urinary Incontinence

Maria Luisa Sanchez Ferrer; Francisco Machado-Linde; María T. Prieto-Sánchez; Anibal Nieto-Diaz

Collaboration


Dive into the Francisco Machado-Linde's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge